2026. Lipofectamine-Mediated CRISPR-Cas9 Delivery Targeting the mecA Gene in Methicillin-Resistant Staphylococcus aureus: A Novel Approach to Reverse Antibiotic Resistance. Wah Academia Journal of Health and Nutrition. 2, 2 (Jun. 2026), 27–35. DOI:https://doi.org/10.63954/bantev40.